Crohn's disease — supplements that address the malabsorption layer
Crohn's disease is treated with anti-inflammatory induction (steroids, enteral nutrition) and disease-modifying maintenance (immunomodulators, biologics — anti-TNF, anti-integrin, anti-IL-23). The supplement layer in Crohn's is mostly about correcting predictable deficiencies caused by terminal ileal disease, surgical resections, malabsorption, and chronic inflammation — plus a small set of plausible inflammation adjuncts. Several supplements that look reasonable for IBS or UC are inappropriate or unhelpful here.
The deficiency-repletion layer — the most important supplement category in Crohn's
Vitamin B12
1,000 mcg/day oral or sublingual; consider intramuscular 1,000 mcg monthly after ileal resection
The terminal ileum is the absorption site for the intrinsic-factor-bound B12 complex. Active terminal-ileal Crohn's, ileal resection, or ileocolic resection effectively guarantees B12 deficiency over time. Check B12 yearly; symptoms include fatigue, neuropathy, glossitis. After ileal resection >20 cm, parenteral B12 is typically required indefinitely. The "sublingual is better" claim is overstated — high-dose oral is sufficient for many even with reduced intrinsic-factor pathway, due to passive diffusion.
Vitamin D3
1,000–4,000 IU/day, titrate to 25-OH-D 30–50 ng/mL; check yearly
Vitamin D deficiency is extremely common in Crohn's (intestinal absorption issues + reduced outdoor activity in chronic illness). Skeletal protection is essential given chronic corticosteroid exposure and increased osteoporotic fracture risk. Observational data also link low D to higher disease activity. Test and replete to a normal range; do not chase very high levels.
Iron (only if iron-deficient; IV preferred in active disease)
Per gastroenterologist; ferrous bisglycinate 25–50 mg if oral tolerated, or IV iron carboxymaltose
Iron deficiency anemia is highly prevalent in Crohn's. Oral iron is poorly tolerated in active disease (GI side effects) and absorption is reduced by inflammation. Ferrous bisglycinate is better tolerated than ferrous sulfate in IBD. IV iron carboxymaltose, sucrose, or isomaltoside is preferred in active disease, after small-bowel surgery, or when oral iron is intolerable. Decision is gastroenterology-directed.
Calcium
1,000–1,200 mg/day total intake (diet + supplement) during chronic corticosteroid exposure
With chronic prednisone exposure, calcium and vitamin D supplementation are standard to reduce osteoporotic fracture risk. Bisphosphonate therapy may be added per bone-density-monitoring guidelines. Calcium citrate is preferred in proton-pump-inhibitor users or with reduced gastric acid.
Zinc and magnesium
Zinc 8–15 mg/day if dietary intake is low; magnesium 200–400 mg/day glycinate or citrate
Chronic diarrhea, malabsorption, and reduced dietary intake make zinc and magnesium deficiency common. Symptoms of deficiency overlap with disease symptoms (zinc: poor wound healing, taste changes; magnesium: muscle cramps, fatigue). Modest supplementation at RDA-equivalent doses is reasonable; high-dose zinc causes copper deficiency over time.
The inflammation-adjunct layer — smaller and more uncertain
Curcumin (bioavailable form)
1–2 g curcuminoids/day in bioavailable form
The Crohn's-specific curcumin RCT base is thinner than the UC base. Small trials and case series suggest possible adjunctive benefit on top of standard therapy. Reasonable adjunct in mild disease on top of optimized standard care; do not expect dramatic results. Anticoagulant interaction caveat at high doses.
Marine omega-3 (EPA/DHA)
2–3 g EPA+DHA/day
The EPIC-1 and EPIC-2 trials of omega-3 for Crohn's maintenance after surgery were negative for primary endpoints. Small trial signal persists for inflammatory marker reduction. Reasonable adjunct for cardiovascular and inflammatory baseline; not a Crohn's-specific intervention with confirmed benefit.
Cholestyramine or colesevelam (prescription, included for completeness)
Per gastroenterologist
Bile-acid diarrhea is common after ileal resection (the resected ileum normally reabsorbs bile acids). Bile-acid binders treat this specifically. Worth raising with your gastroenterologist if post-resection diarrhea persists despite quiescent inflammation.
What to skip
- High-fiber supplements during active inflammation or stricturing disease — bulk-forming fiber can precipitate obstruction in strictured small bowel.
- "Leaky gut healing" stacks (high-dose L-glutamine, marshmallow root, slippery elm) — minimal Crohn's-specific evidence; the "leaky gut" framing is not a clinical management target.
- Echinacea, astragalus, AHCC, andrographis — immune-stimulant herbs inappropriate in autoimmune-driven IBD.
- Aloe vera as monotherapy — minimal trial evidence in Crohn's (UC evidence is also limited); anthraquinone-containing forms are stimulant laxatives inappropriate here.
- Probiotics with the expectation of disease modification — Crohn's probiotic trials have been largely negative. VSL#3/Visbiome has signal in UC and pouchitis, not Crohn's.
- "Stem cell" oral supplements, IV vitamin "drips" — no plausible mechanism, no IBD-specific trial support.
- Stopping biologics or immunomodulators in remission "to detox" — predictable relapse risk.
The non-supplement layer that matters more
Biologic/immunomodulator adherence, smoking cessation (smoking dramatically worsens Crohn's course and reduces medication efficacy — this is the single largest lifestyle lever in Crohn's), exclusive enteral nutrition as an induction option (particularly in pediatric Crohn's), Mediterranean or Crohn's-specific exclusion diets in remission with dietitian guidance, vaccine status (live vaccines avoided on biologics; flu/COVID/pneumococcal indicated), colorectal cancer surveillance, bone-density monitoring, and dermatology evaluation for biologic-associated skin findings.